Clinical Trial Update: Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial program PREMIER evaluates angiotensin-neprilysin inhibition in hospitalized patients with worsening heart failure. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Saga University | Conditions: Heart Failure | Phase 4 | Status: ACTIVE_NOT_RECRUITING